Correlation Between BB Biotech and Invesco AT1

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BB Biotech and Invesco AT1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and Invesco AT1 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BB Biotech AG and Invesco AT1 Capital, you can compare the effects of market volatilities on BB Biotech and Invesco AT1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of Invesco AT1. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and Invesco AT1.

Diversification Opportunities for BB Biotech and Invesco AT1

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between BION and Invesco is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and Invesco AT1 Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco AT1 Capital and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with Invesco AT1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco AT1 Capital has no effect on the direction of BB Biotech i.e., BB Biotech and Invesco AT1 go up and down completely randomly.

Pair Corralation between BB Biotech and Invesco AT1

Assuming the 90 days trading horizon BB Biotech AG is expected to generate 8.54 times more return on investment than Invesco AT1. However, BB Biotech is 8.54 times more volatile than Invesco AT1 Capital. It trades about 0.32 of its potential returns per unit of risk. Invesco AT1 Capital is currently generating about -0.12 per unit of risk. If you would invest  3,540  in BB Biotech AG on October 21, 2024 and sell it today you would earn a total of  280.00  from holding BB Biotech AG or generate 7.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy93.75%
ValuesDaily Returns

BB Biotech AG  vs.  Invesco AT1 Capital

 Performance 
       Timeline  
BB Biotech AG 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in BB Biotech AG are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Invesco AT1 Capital 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Invesco AT1 Capital has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Invesco AT1 is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

BB Biotech and Invesco AT1 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BB Biotech and Invesco AT1

The main advantage of trading using opposite BB Biotech and Invesco AT1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, Invesco AT1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco AT1 will offset losses from the drop in Invesco AT1's long position.
The idea behind BB Biotech AG and Invesco AT1 Capital pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA